Study Stopped
The study was unable to meet recruitment targets
Negative Pressure Dressing Therapy in Soft Tissue Sarcoma Surgery
Negative Pressure Dressings Versus Non-negative Pressure Dressing for Wound Care Following Soft Tissue Sarcoma Excision
1 other identifier
interventional
17
1 country
1
Brief Summary
This randomised controlled trial aims to evaluate the difference in surgical site infection following excision of soft tissue sarcomas. The intervention is a negative wound pressure therapy dressing for 120 hours, the control is standard absorbent dressings
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 1, 2016
CompletedFirst Posted
Study publicly available on registry
September 15, 2016
CompletedStudy Start
First participant enrolled
October 18, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2020
CompletedNovember 26, 2021
November 1, 2021
3.5 years
September 1, 2016
November 16, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Surgical Site Infection (proportion)
As diagnosed by independent observer according to the Healthcare Protection Agency (UK) guidelines
30 days
Secondary Outcomes (4)
Time to wound dryness (nominal scale)
30 days
Delay to discharge form hospital (nominal scale)
30 days
Adverse events (count)
30 days
Cost analysis (comparative nominal scale in £)
30 days
Study Arms (2)
Negative Pressure Wound Therapy
EXPERIMENTAL120 hours of negative pressure wound therapy (ActiVAC, KCI) applied to a primarily closed ('acute') wound.
Standard dressings
ACTIVE COMPARATORAbsorbant dressings applied in a standard fashion, i.e. only changed as necessary
Interventions
Current absorbent dressing is 'tegaderm with absorbent pad' (3M)
Eligibility Criteria
You may qualify if:
- Adults undergoing primary soft tissue sarcoma excision which is primarily closed.
You may not qualify if:
- Unable to consent
- Children
- Post radiation sarcomas or sarcoma in presence of active infection
- Multiple metastatic disease
- Presence of Endoprosthesis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Glasgow Royal Infirmary
Glasgow, Scotland, G31 2ER, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sanjay Gupta, MBBS
NHS Greater Glasgow and Clyde
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 1, 2016
First Posted
September 15, 2016
Study Start
October 18, 2016
Primary Completion
April 28, 2020
Study Completion
April 28, 2020
Last Updated
November 26, 2021
Record last verified: 2021-11